Table 2 Sample characteristics at before relapse (newly diagnosed) and relapse in the same AML patient (n = 15).

From: Correction: Nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4

  

Before relapse

Relapse

P Value

WBC (×109/L)

Median

13.74

15.44

0.736

Range

2.11–223.39

0.66–185.89

HB (×109/L)

Median

79.00

94.00

0.580

Range

44.00–129.00

23.00–129.00

PLT (×109/L)

Median

51.00

24.00

0.623

Range

4.00–346.00

6.00–402.00

RBC (×109/L)

Median

2.25

2.63

0.415

Range

1.27–4.06

1.27–3.85

BM Blast (%)

Median

42.00

71.75

0.073

Range

21.29–93.57

22.06–92.14

Gene mutation

Mutation

4 (26.7%)

6 (40%)

0.456

No mutation

11 (73.4%)

9 (60%)

  1. BM bone marrow, HB hemoglobin, PLT platelet and WBC white blood cell, RBC red blood cell.
Back to article page